Document Detail

Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes.
MedLine Citation:
PMID:  20649635     Owner:  NLM     Status:  In-Process    
We conducted a three-arm, parallel-group, randomized, controlled trial to compare the effects of rosiglitazone and physical exercise on endothelial function in patients with coronary artery disease and impaired fasting glucose or impaired glucose tolerance over a 6-month period. Group A received rosiglitazone tablets 8 mg daily (n = 16), group B underwent a structured physical exercise programme (n = 15) and group C served as a control group (n = 12). At baseline and after 6 months, brachial artery ultrasound imaging was performed to assess reactive flow-mediated dilation (FMD). Rosiglitazone treatment and exercise both led to significant improvements in insulin resistance at 6 months, whereas no change was observed in control patients. FMD improved significantly in physical exercise patients, whereas no change could be observed in patients receiving rosiglitazone or in the control group. Between-group comparisons also showed a significant relative improvement in FMD in exercise patients compared with rosiglitazone.
S Desch; M Sonnabend; J Niebauer; S Sixt; M Sareban; I Eitel; S de Waha; H Thiele; M Blüher; G Schuler
Related Documents :
871105 - Enhanced diagnostic power of exercise testing for myocardial ischemia by addition of po...
1991365 - Accuracy of exercise electrocardiography in detecting physiologically significant coron...
1576855 - Exercise testing and training of the elderly coronary patient.
12834565 - Physical activity in the prevention of atherosclerotic coronary heart disease.
21801125 - Effect of exercise training on the cardiovascular and biochemical parameters in women w...
10946035 - Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in pa...
Publication Detail:
Type:  Letter    
Journal Detail:
Title:  Diabetes, obesity & metabolism     Volume:  12     ISSN:  1463-1326     ISO Abbreviation:  Diabetes Obes Metab     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883645     Medline TA:  Diabetes Obes Metab     Country:  England    
Other Details:
Languages:  eng     Pagination:  825-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: p...
Next Document:  Niche conservatism as an emerging principle in ecology and conservation biology.